Skip to main content

Is it the time to implement the routine use of distress thermometer among Egyptian patients with newly diagnosed cancer?

Research Authors
Safa Abdel-Sattar Ahmed Khaled
Research Date
Research Department
Research Journal
BMC Cancer
Research Publisher
Springer
Research Rank
Q3
Research Vol
20
Research Year
2020
Research_Pages
1-8
Research Abstract

Background: The distress thermometer (DT) is an effective tool for identifying distress among cancer patients
worldwide. However, DT has not been studied in Egyptian patients. We aimed to study the prevalence of distress
among Egyptian patients with different types of cancers using DT.
Methods: A total of 550 patients with newly diagnosed hematological and solid cancers who were followed up at
3 Oncology Centers in Egypt were enrolled. They completed a sociodemographic and clinical status questionnaire,
the DT and the Problem List (PL) scale.
Results: At a DT cut-off score of ≥4, 46% of patients had significant distress, which was related to the tumor site
and stage. The most frequent problems reported were treatment decision (64.4%), worry (47%), and fears (44.5%). In
univariate logistic regression analysis, participants who had significant distress described 23 out of 36 problems in
the practical, family, emotional, and physical areas. After adjustment to sociodemographic and clinical
characteristics, multivariable analysis confirmed that insurance, depression, fear, sadness, worry, loss of interest in
usual activity, and sleep were independent factors associated with significant distress in cancer patients.
Conclusions: Almost half of Egyptian patients newly diagnosed with cancer reported significant distress. Those
who had significant distress described extra problems in the practical, family, emotional, and physical areas. We
recommend the routine use of DT for screening Egyptian patients with cancer, as well as the involvement of the
psycho-oncology and social services, at the time of their initial diagnosis.